Media
Bloomberg: Trump Drug Pricing Order Spurs Doubts With Staff Cuts, Tariffs
But Merith Basey, executive director of Patients For Affordable Drugs, said in a statement that the change wouldn’t lower costs, but “hand drug companies four additional years to price-gouge patients.”